🔗 Share this article

A shadow economy for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, according to recent findings.

Investigational Treatment Gaining Popularity Online

The experimental drug, which is still in clinical trials, is being promoted by online personalities for its supposed weight-reducing effects. Viewers are encouraged to contact these profiles directly for supplier links, while also receiving discount codes.

Active Trade on Social Networks

Additionally, a robust market exists on messaging services, where groups with thousands of members share comparison images, administration instructions and assertions of next-day British shipping. Sellers market the substance there before redirecting customers to other platforms for transactions.

Learning About The Experimental Drug

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist patients lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Medical Professionals Express Worries

However, physicians and pharmacists have warned that the sale of what remains an unapproved drug in the United Kingdom is a cause for concern and could lead to individuals administering substances of unknown origin.

Some experts said the popularity for the experimental drug could be linked to the increasing price of approved weight loss products such as Mounjaro.

Legal Status and Enforcement

Marketing retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unlicensed drug that cannot be promoted or supplied for personal consumption under the British medical regulations.

Several influencers try to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still breach medicines, marketing, and customer laws, risking penalties, legal action or imprisonment.

Platform Response and Material Removal

Based on TikTok, the service has removed problematic content and banned related hashtags and search suggestions. The organization said it was committed to keeping the platform safe and investing in enhancing enforcement strategies.

Digital Trading Activities

Investigations also discovered groups with up to 9,000 members marketing retatrutide using the platform's built-in discovery tool, which functions like a public directory. Entering “retatrutide” instantly brings up channels with numerous of members, filled with photos of slimming results, glowing reviews and step-by-step instructions for mixing or administering at home.

Within minutes of entering one community, a seller shared WhatsApp details, where most transactions occur. The seller provided an instruction manual and guaranteed delivery within 48 hours. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about body mass, medical conditions or previous experience.

Product Details and Pricing

Within these groups, posts display dark colored parcels with Royal Mail stickers, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at residence with purified liquid, or ready-to-use injectors typically sold at 160 pounds for 20mg. When asked how much time a pen should be used, sellers give conflicting responses varying between a few weeks to “depends on your body”.

Platform Oversight and Security Measures

A spokesperson for Telegram stated it regularly moderated harmful material on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting materials they cannot confirm. Even if the research behind this drug is sound, these online products may not include what they claim,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the increase in interest to recent price rises for authorized slimming drugs such as Mounjaro. “With costs increasing, patients are using social media. But counterfeit treatments are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she said.

Her team has previously seen individuals harmed by self-injection from unverified suppliers. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” stated Wyllie. “These materials could be impure or incorrectly dosed.”

Manufacturer Statement

A spokesperson from Eli Lilly said retatrutide was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a Lilly experimental substance not yet authorized … may expose users to possibly serious health risks”.